Type 2 Diabetes Drugs Associated With Serious Adverse Reactions
Type 2 Diabetes Drugs Serious Adverse Reactions. The personal injury attorneys at Parker Waichman LLP are investigating the association between SGLT2 Type 2 diabetes medications and heart attack, stroke, renal failure, diabetic ketoacidosis, or the need for amputations and are also investigating potential lawsuits. If you … [Read more...]
New Study Shows Increased Risk of Diabetic Ketoacidosis with SGLT2 Drugs
SGLT2 Drugs Increased Risk Of Diabetic Ketoacidosis. Researchers from Brigham and Women's Hospital in Boston say a new class of type diabetes drugs is associated with an increased risk of diabetic ketoacidosis, a serious complication. In 2015, the U.S. Food and Drug Administration (FDA) issued a warning about the … [Read more...]
Janssen Facing Suit due to Alleged Xarelto Complications
Plaintiff filed A Suit Against Janssen Promotion And Marketing Xarelto. On September 1, 2016, a plaintiff filed a suit in St. Clair County Circuit Court against Janssen Research & Development, LLC, a subsidiary of Johnson & Johnson (J&J), creators of the anticoagulant, Xarelto. The lawsuit states that the plaintiff was … [Read more...]
Janssen Facing Suit Due to Alleged Xarelto Complications
a suit in St. Clair County Circuit Court against Janssen. Xarelto Background and Side Effects. On September 1, 2016, a plaintiff filed a suit in St. Clair County Circuit Court against Janssen Research & Development, LLC, a subsidiary of Johnson & Johnson (J&J), creators of the anticoagulant, Xarelto. The lawsuit … [Read more...]
Judge Extends Filing Deadline for Xarelto Lawsuits
Flood of New File Case Against Xarelto. In response to a flood of new Xarelto bleeding lawsuits, Louisiana federal Judge Eldon Fallon has given victims an additional 90 days to file lawsuits against Janssen for inclusion in the multidistrict litigation. Judge Fallon oversees the Xarelto multidistrict litigation in the Eastern … [Read more...]
Janssen Failed To Disclose Risk Of Ketoacidosis With Invokana
Janssen Failed To Disclose Diabetic Ketoacidosis Risks. A lawsuit has been filed on behalf of a Florida woman who alleges that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to warn about the risk of ketoacidosis with its Type 2 diabetes medication, Invokana. According to court documents, the plaintiff began … [Read more...]
Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana--Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)--, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, a condition that occurs when too much acid builds up … [Read more...]
Risperdal Trial Paused to Turn Over More Evidence
Risperdal Trial Paused. A trial in Philadelphia state court overbreast growth in an adolescent boy allegedly caused by the antipsychotic drug Risperdal (risperidone), has been paused until early December so the company can turn over , has been paused until early December so the company can turn over more evidence for the boy's … [Read more...]
